IQS Tech Transfer Salut

The technological capabilities focus on the fields of advanced and emerging therapies, biomedicine, nanomedicine and the development of new drugs.

Expertise of Materials Engineering Group:

• Biodegradable polymers, biomaterials for scaffolds and advanced drug release systems based on polymeric nanoparticles.
• Functionalization of PLGA nanoparticles, design of non-viral gene therapy vectors and formulation of nanosystem-based mRNA vaccines.
• Development of peptides for biomedical applications, modified therapeutic proteins and vectored drug releases systems targeting the brain.
• Hybrid vectors for gene therapy, local RNA administration systems and toxicity and efficacy studies in pre-clinical models.
• Nanotechnology for cancer treatment and cartilage regeneration.
• Therapies for Alzheimer’s and other neuro-degenerative diseases

Expertise of Vascular Engineering and Applied Biomedicine Groups:

• Development of bio-materials for the treatment of cardiovascular pathologies.
• Production of recombinant proteins and bio-processes.

Expertise of Biological Chemistry and Biotechnology Groups:

• Study of the pathological mechanisms of Lafora disease and the glycogen metabolism.